P06241 (FYN_HUMAN) Homo sapiens (Human)
Tyrosine-protein kinase Fyn UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
50 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Fyn SH2 domain in complex with the natural inhibitory phosphotyrosine peptide |
Heteromer | |||||
Assess | ||||||
NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE, 22 STRUCTURES |
Heteromer P03079; | |||||
Assess | ||||||
NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE, MINIMIZED AVERAGE STRU… |
Heteromer P03079; | |||||
Assess | ||||||
Human Fyn-SH2 domain in complex with a synthetic high-affinity phospho-peptide |
Heteromer P03079; | 1×15P; 1×NA; | ||||
Assess | ||||||
Crystal Structure of the Human Fyn SH3 domain in complex with a peptide from the Hepatitis C virus … |
Heteromer P26663; | 1×GOL; 1×CL; 1×NA; | ||||
Assess | ||||||
Crystal structure of SAP/FynSH3/SLAM ternary complex |
Heteromer O60880; Q13291; | 1×FLC; | ||||
Assess | ||||||
NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE KINASE COMPLEXED WITH THE SYNTH… |
Heteromer P27986; | |||||
Assess | ||||||
NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE COMPLEXED WITH THE SYNTHETIC PE… |
Heteromer P27986; | |||||
Assess | ||||||
Tau-S214 Phosphorylation Inhibits Fyn Kinase Interaction and Increases the Decay Time of NMDAR-medi… |
Heteromer P10636; | |||||
Assess | ||||||
HIV-1 NEF PROTEIN IN COMPLEX WITH R96I MUTANT FYN SH3 DOMAIN |
Heteromer P03406; | 2×PBM; | ||||
Assess | ||||||
Crystal structure of HIV-1 NEF Fyn-SH3 R96W variant |
Heteromer P03406; | |||||
Assess | ||||||
V-1 NEF PROTEIN IN COMPLEX WITH WILD TYPE FYN SH3 DOMAIN |
Heteromer P03406; | |||||
Assess | ||||||
Complex of the human FYN SH3 and monobody binder |
Heteromer | |||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE SH3 DOMAIN IN HUMAN FYN; COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF… | homo-4-mer | |||||
Assess | ||||||
Crystal structure of the Fyn-SH3 domain in complex with the high affinity peptide APP12 | homo-4-mer | |||||
Assess | ||||||
Swapped dimer of the human Fyn-SH2 domain | homo-2-mer | 5×PO4; 3×EDO; | ||||
Assess | ||||||
Crystal Structure of Fyn kinase domain complexed with staurosporine | monomer | 1×STU; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF FYN SH3-SH2 | monomer | |||||
Assess | ||||||
Structure of Fyn protein SH2 bound | monomer | |||||
Assess | ||||||
human Fyn SH2 free state | monomer | |||||
Assess | ||||||
Fragment of a tyrosine-protein kinase | monomer | 1×GOL; 14×UNX; | ||||
Assess | ||||||
His-tagged Fyn SH3 domain R96I mutant | monomer | |||||
Assess | ||||||
human Fyn SH3 domain R96I mutant, crystal form I | monomer | 1×PG4; | ||||
Assess | ||||||
Fyn SH3 domain R96W mutant, crystallized with 18-crown-6 | monomer | 2×O4B; | ||||
Assess | ||||||
PHOSPHOTRANSFERASE | monomer | |||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant in complex with VSL12 … | monomer | |||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 4.5 | monomer | 1×PGE; | ||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant in complex with VSL12 … | monomer | |||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant in complex with VSL12 … | monomer | 1×CIT; | ||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 6.0 | monomer | |||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T at pH 4.5 | monomer | 1×ACT; | ||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E129Q at pH 4.0 | monomer | |||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 5.0 with PEG | monomer | 1×PGE; | ||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 5.0 | monomer | |||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant in complex with VSL12 … | monomer | |||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 4.0 | monomer | 1×ACT; | ||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain A95S-D99T mutant in space group P21 | monomer | 1×FMT; 4×NA; | ||||
Assess | ||||||
human Fyn SH3 domain R96I mutant, crystal form II | monomer | |||||
Assess | ||||||
Crystal structure of the human Fyn SH3 R96W mutant | monomer | 1×PG5; | ||||
Assess | ||||||
Inferential Structure Determination of the Fyn SH3 domain using NOESY data from a 15N,H2 enriched p… | monomer | |||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 3.0 with PEG | monomer | 1×PG4; 1×SO4; | ||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain A95S-D99T mutant in C21 space group | monomer | 2×NA; 1×SO4; | ||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain in space group P1 at pH 7.5 | monomer | 1×NA; | ||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain in space group C21 at pH 7.5 | monomer | 1×NA; | ||||
Assess | ||||||
Crystal Structure of the Human Fyn SH3 domain in complex with the synthetic peptide VSL12 | monomer | 1×NA; | ||||
Assess | ||||||
NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE, FAMILY OF 20 STRUCTURES | monomer | |||||
Assess | ||||||
NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE, MINIMIZED AVERAGE (PROBMAP) ST… | monomer | |||||
Assess | ||||||
Crystal Structure of the Human Fyn SH3 domain | monomer | 2×GOL; 5×FMT; 2×NA; | ||||
Assess | ||||||
Crystal structure of the Fyn SH3 domain mutant E129Q in space group C21 at pH 4.0 | monomer | 2×FMT; 1×NA; | ||||
Assess | ||||||
Designed Enzyme SH3-588 (Catechol O-methyltransferase catalytic domain and Src homology 3 binding d… | monomer | 1×SAH; 1×K; | ||||
Assess |
2 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
2h8h.1.A | monomer | 0.79 | 75.85 | |||
Assess | ||||||
1y57.1.A | monomer | 0.79 | 77.61 | |||
Assess |
6 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 2h8h.1.A | monomer | 0.81 | 76.69 | ||
Assess | ||||||
Isoform 2 | 1y57.1.A | monomer | 0.80 | 1×MPZ; | 78.71 | |
Assess | ||||||
Isoform 3 | 2src.1.A | monomer | 0.78 | 80.45 | ||
Assess | ||||||
Isoform 3 | 1y57.1.A | monomer | 0.77 | 80.45 | ||
Assess | ||||||
Isoform 3 | 3u4w.1.A | monomer | 0.75 | 79.48 | ||
Assess | ||||||
Isoform 3 | 4xi2.1.A | monomer | 0.70 | 37.57 | ||
Assess |